Evidence map›Paper›PMID 39470860›Full record

ArticleJournal of computer-aided molecular design2024

Comparative assessment of physics-based in silico methods to calculate relative solubilities.

Adiran Garaizar Suarez, Andreas H Göller, Michael E Beck, Sadra Kashef Ol Gheta, Katharina Meier

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Data-Driven Critical Evaluation of the General Solubility Equation.Journal of chemical information and modeling · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adiran Garaizar SuarezBayer AG, Pharmaceuticals, Structural Biology & Computational Design, Wuppertal, Germany.
Andreas H GöllerBayer AG, Pharmaceuticals, Structural Biology & Computational Design, Wuppertal, Germany.
Michael E BeckBayer AG, Crop Science, Data Science, Monheim, Germany.
Sadra Kashef Ol GhetaBayer AG, Crop Science, Data Science, Monheim, Germany.
Katharina MeierBayer AG, Pharmaceuticals, Structural Biology & Computational Design, Wuppertal, Germany. katharina.meier2@bayer.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relative solubilities, i.e. whether a given molecule is more soluble in one solvent compared to others, is a critical parameter for pharmaceutical and agricultural formulation development and chemical synthesis, material science, and environmental chemistry. In silico predictions of this crucial variable can help reducing experiments, waste of solvents and synthesis optimization. In this study, we evaluate the performance of different physics-based methods for predicting relative solubilities. Our assessment involves quantum mechanics-based COSMO-RS and molecular dynamics-based free energy methods using OPLS4, the open-source OpenFF Sage, and GAFF force fields, spanning over 200 solvent-solute combinations. Our investigation highlights the important role of compound multimerization, an effect which must be accounted for to obtain accurate relative solubility predictions. The performance landscape of these methods is varied, with significant differences in precision depending on both the method used and the solute considered, thereby offering an improved understanding of the predictive power of physics-based methods in chemical research.

Indexed as

Molecular Dynamics SimulationQuantum TheorySolubilitySolventsThermodynamicsComputer SimulationPhysicsSolventsFree energy calculationsPhysics-based approachesSolubility

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.